On October 27, 2023, Helix BioPharma Corp. closed the transaction. In connection with the closing, the company paid a cash fee of 10% of gross proceeds raised to an eligible finder.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 CAD | 0.00% | +4.55% | +9.52% |
08/04 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
28/03 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.52% | 38.63M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it has received CAD 2.998 million in funding